Anika Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent
Anika Therapeutics, Inc. (ANIK) reported Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent of 0.00% for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-06.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities · last filed 2020-03-06
- Anika Therapeutics, Inc. effective income tax rate reconciliation, deduction, qualified production activity, percent for fiscal 2019 was 0.00%.
- Anika Therapeutics, Inc. effective income tax rate reconciliation, deduction, qualified production activity, percent for fiscal 2018 was 0.00%, a 100.00% decline from fiscal 2017.
- Anika Therapeutics, Inc. effective income tax rate reconciliation, deduction, qualified production activity, percent for fiscal 2017 was 2.80%, a 3.45% decline from fiscal 2016.
- Anika Therapeutics, Inc. effective income tax rate reconciliation, deduction, qualified production activity, percent for fiscal 2016 was 2.90%, a 0.00% change from fiscal 2015.
| Period end | Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent 12 month | Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent 12 month as first filed |
|---|---|---|
| 2019-12-31 | 0.00% 10-K · filed 2020-03-06 | |
| 2018-12-31 | 0.00% 10-K · filed 2020-03-06 | |
| 2017-12-31 | 2.80% 10-K · filed 2020-03-06 | |
| 2016-12-31 | 2.90% 10-K · filed 2019-02-27 | |
| 2015-12-31 | 2.90% 10-K · filed 2018-02-27 | -2.90% 10-K · filed 2016-03-10 |
| 2014-12-31 | 1.70% 10-K · filed 2017-02-24 | -1.70% 10-K · filed 2015-03-13 |
| 2013-12-31 | -2.40% 10-K · filed 2016-03-10 | |
| 2012-12-31 | -3.60% 10-K · filed 2015-03-13 | |
| 2011-12-31 | -2.30% 10-K · filed 2014-03-13 | |
| 2010-12-31 | -2.10% 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |